Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2018–June 2019
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
In April 2016, all oral polio vaccination switched from trivalent OPV (tOPV; containing vaccine virus types 1, 2, and 3) to bivalent OPV (bOPV; containing types 1 and 3) (2). Monovalent type 2 OPV (mOPV2) is used in response campaigns to control type 2 cVDPV (cVDPV2) outbreaks. This report presents data on cVDPV outbreaks detected during January 2018-June 2019 (as of September 30, 2019). Compared with January 2017-June 2018 (3), the number of reported cVDPV outbreaks more than tripled, from nine to 29; 25 (86%) of the outbreaks were caused by cVDPV2. The increase in the number of outbreaks in 2019 resulted from VDPV2 both inside and outside of mOPV2 response areas. GPEI is planning future use of a novel type 2 OPV, stabilized to decrease the likelihood of reversion to neurovirulence. However, all countries must maintain high population immunity to decrease the risk for cVDPV emergence. Cessation of all OPV use after certification of polio eradication will eliminate the risk for VDPV emergence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A long-standing disadvantage of using OPVs is that attenuated vaccine strains can revert to a neuropathogenic phenotype during their replication in the intestinal tract [9,10,11,12,13,14].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There are cases of paralytic polio due to the loss of viral attenuation in the oral poliovirus vaccine (OPV), known as vaccine-derived poliovirus (VDPV).”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update on Vaccine-Derived Polioviruses-Worldwide, January 2017–June 2018
Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Sutter, R. W., Wassilak, S. G. F., & Burns, C. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6742a5 · Cited by 197 · cited 3×
“The number of cVDPV outbreaks detected worldwide increased from nine in six countries during the January 2017– June 2018 reporting period (3) to 29 in 15 countries during January 2018–June 2019; 25 (86%) outbreaks were cVDPV2 emergences, 18 (72%) of which were detected during the first half of 2019 in Central and West…”
BackgroundResultInfluentialSelf-citationVan Damme, P., De Coster, I., Bandyopadhyay, A. S., Revets, H., Withanage, K., De Smedt, P., Suykens, L., Oberste, M. S., Weldon, W. C., Costa-Clemens, S. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31279-6 · Cited by 141
Self-citationProgress Toward Polio Eradication — Worldwide, January 2017–March 2019
Greene, S. A., Ahmed, J., Datta, S. D., Burns, C. C., Quddus, A., Vertefeuille, J. F., & Wassilak, S. G. F. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6820a3 · Cited by 80
Self-citationProgress Toward Polio Eradication-Worldwide, January 2016–March 2018
Khan, F., Datta, S. D., Quddus, A., Vertefeuille, J. F., Burns, C. C., Jorba, J., & Wassilak, S. G. F. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6718a4 · Cited by 66
Self-citationProgress Toward Poliomyelitis Eradication — Nigeria, January 2018–May 2019
Adamu, U. S., Archer, W. R., Braka, F., Damisa, E., Siddique, A. R., Baig, S., Higgins, J., Sume, G. E., Banda, R., Korir, C., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6829a3 · Cited by 51 · cited 9×
“Expansion of environmental surveillance provides critical indicators for early VDPV detection (9); for example, environmental surveillance detection in Cameroon and Ghana in 2019 confirmed circulation of the cVDPV2 emergence of JIS-1 outside Nigeria in the absence of detection of AFP (Cameroon) or before detection (Gh…”
BackgroundInfluentialSelf-citationSurveillance to Track Progress Toward Polio Eradication — Worldwide, 2017–2018
Patel, J. C., Diop, O. M., Gardner, T., Chavan, S., Jorba, J., Wassilak, S. G. F., Ahmed, J., & Snider, C. J. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6813a4 · Cited by 48 · cited 1×
“Expansion of environmental surveillance provides critical indicators for early VDPV detection (9); for example, environmental surveillance detection in Cameroon and Ghana in 2019 confirmed circulation of the cVDPV2 emergence of JIS-1 outside Nigeria in the absence of detection of AFP (Cameroon) or before detection (Gh…”
BackgroundSelf-citationMbaeyi, C., Alleman, M. M., Ehrhardt, D. T., Wiesen, E., Burns, C. C., Liu, H., Ewetola, R., Seakamela, L., Mdodo, R., Ndoutabé, M., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809a2 · Cited by 32 · cited 6×
“BAN-1 cases were detected in provinces in South-Central and Puntland zones of Somalia (Banadeer, Bari, Gedo, Hiran, Lower Juba, Sool, and Togdheer) and in the Somali region of Ethiopia.”
BackgroundInfluentialSelf-citationDiop, O. M., Asghar, H., Gavrilin, E., Gumede, N., Rey-Benito, G. J., Paladin, F. J., Pattamadilok, S., Zhang, Y., Goel, A., & Quddus, A. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6620a4 · Cited by 31 · cited 1×
“† In April 2016, all oral polio vaccination switched from trivalent OPV (tOPV; containing vaccine virus types 1, 2, and 3) to bivalent OPV (bOPV; containing types 1 and 3) (2).”
BackgroundSelf-citationBauri, M., Wilkinson, A. L., Ropa, B., Feldon, K., Snider, C. J., Anand, A., Tallis, G. F., Boualam, L., Grabovac, V., Avagyan, T., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6805a6 · Cited by 16 · cited 1×
“cVDPV1 isolates from acute flaccid paralysis (AFP) cases and environmental surveillance (testing of sewage samples for poliovirus) continued to be detected from the previously reported Papua New Guinea outbreak (4) (Table); the AFP”
Background
Cited by
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
Alleman, M. M., Jorba, J., Greene, S. A., Diop, O. M., Iber, J., Tallis, G., Goel, A., Wiesen, E., Wassilak, S. G. F., & Burns, C. C. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6916a1 · Cited by 93
Self-citationCurrent view on novel vaccine technologies to combat human infectious diseases
Matić, Z., & Šantak, M. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11713-0 · Cited by 97
Progress toward polio eradication—worldwide, January 2018–March 2020.
Chard, A. N., Datta, S. D., Tallis, G., Burns, C. C., Wassilak, S. G. F., Vertefeuille, J. F., & Zaffran, M. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6925a4 · Cited by 83
Self-citationLee, B. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1844525 · Cited by 76
Enteric Viral Co-Infections: Pathogenesis and Perspective
Makimaa, H., Ingle, H., & Baldridge, M. T. (2020) · Viruses · doi:10.3390/v12080904 · Cited by 74
Metadata
- Authors
- Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Quddus, A., Sutter, R., Vertefeuille, J. F., Wenger, J., Wassilak, S. G. F., Pallansch, M. A., & Burns, C. C.
- Affiliations
- Gates Foundation (US)
- Corresponding author
- Jorba, Jaume
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2019-11-15
- Volume
- 68
- Issue
- 45
- Pages
- 1024-1028
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC6855511
- OpenAlex
- W2986629155
- Cited by
- 83
- References
- 9
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 15 · 2022: 18 · 2021: 14 · 2020: 24
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- vaccine-derived poliovirus, polio eradication, herd immunity, polio surveillance
- MeSH terms
- Disease Outbreaks, Humans, Poliomyelitis, Poliovirus Vaccine, Oral, Serotyping, Global Health, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2018–June 2019. https://app.cochat.ai/papers/10.15585/mmwr.mm6845a4
- The paper
- Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Quddus, A., Sutter, R., Vertefeuille, J. F., Wenger, J., Wassilak, S. G. F., Pallansch, M. A., & Burns, C. C. (2019). Update on Vaccine-Derived Poliovirus Outbreaks-Worldwide, January 2018–June 2019. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6845a4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.